Analysis of drugs procurement to ensure the provision of medical care in hospitals

Abstract

One of the legislative innovations aimed to reduce irregularities in public procurement, is the emergence of new actors — an «expert» and «expert organization», i.e. people with special knowledge, experience, expertise in the field of science, technology, art or craft required for the examination, as well as for auditing. Th is work is devoted to the possibility of carrying out an independent examination of drugs procurement for health care organizations is fixed.